Stay updated on Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial
Sign up to get notified when there's something new on the Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial page.

Latest updates to the Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe page footer shows Revision: v3.6.5, replacing v3.6.4, indicating a small system revision. No substantive study information appears to be changed.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a backend/template update. This change does not modify the study content, eligibility criteria, or user-visible information on the UP-NEXT page.SummaryDifference0.0%

- Check43 days agoChange DetectedThe page now shows a revised site version indicator (v3.6.3), replacing the previous (v3.6.2), indicating a backend update to the ClinicalTrials.gov entry.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, signaling a recent update to the Study Details page's version. This appears to be a minor maintenance/metadata update rather than a substantive change to study information.SummaryDifference0.0%

- Check65 days agoChange DetectedRecruitment status now indicates the study is no longer looking for participants. The page adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment label along with a revision tag to v3.6.0.SummaryDifference0.4%

- Check72 days agoChange DetectedThe page revision indicator has advanced from v3.5.4 to v3.5.5, signaling a minor update to the page's metadata rather than changes to study details.SummaryDifference0.0%

Stay in the know with updates to Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial page.